Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

301310 of over 1000 results

Applied Filters:

Resource Utilization and Cost in Management of Febrile Infants After the 2021 Clinical Guideline
2025 · Akron Children's Hospital, · Northeast Ohio Medical University
This article is about a study on how resources and costs are used to care for infants with fevers after new guidelines were introduced in …
Changes in the Management of Children with Brief Resolved Unexplained Events (BRUEs)
2019 · University of Pittsburgh, · University of Pittsburgh Medical Center
This article discusses changes in managing children with brief resolved unexplained events (BRUE), focusing on reduced hospitalization rates and the importance of clinical evaluation and …
Adult Tourniquet for Use in School-Age Emergencies
2019 · Nemours Children's Health
This article explains how adult Combat Application Tourniquets (CAT) can be used effectively on children aged 6 to 16 years. It describes a study that …
Age, Adverse Childhood Experiences, and Healthcare Utilization
2024 · Children's Hospital of Orange County, · University of California at Irvine
This article with video abstract is about a study that looks at how age and bad experiences in childhood affect the use of healthcare. It …
Fine Particles in Wildfire Smoke and Pediatric Respiratory Health in California
2021 · University of California, San Diego
This article is about how wildfire smoke affects children's breathing in California. It describes that fine particles from wildfires, known as PM2.5, are much more …
Immunization for Respiratory Syncytial Virus-Promises and Pitfalls
2024 · Northwestern University, · The University of Chicago Medicine, · Endeavor Health
This editorial discusses the potential benefits and challenges of vaccines for the respiratory syncytial virus (RSV). It explains how RSV affects children and older adults, …
Pricey or Priceless: Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention in Infants
2024 · University of Antwerp
This comment discusses the cost-effectiveness of preventing RSV in infants. It compares different strategies, like using monoclonal antibodies (nirsevimab) and a maternal vaccine (MV). It …
Introduction to This JPIDS Supplement: All Infant Protection Against Serious RSV Disease
2024 · State University of New York - Upstate Medical University
This article describes the challenges and advancements in protecting infants from serious RSV disease. It highlights the unpredictability of RSV, especially during the COVID-19 pandemic, …
Single-Dose Nirsevimab Prevents RSV Infection
2021 · University of the Witwatersrand, · University of Colorado
This article commentary discusses a study on nirsevimab, a single-dose treatment that helps prevent RSV infections in preterm infants. Conducted across 164 sites in 23 …
Parent Perspectives on Nirsevimab for Their Newborn
2024 · Yale School of Medicine, · Yale University
This article explores how parents feel about using nirsevimab for their newborns. Nirsevimab is a medicine that helps protect babies from RSV, a common virus …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
301310 of over 1000 results